Point72 Asset Management, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ)

Filing Manager: Point72 Asset Management, L.P.
Reporting Manager: Steven A. Cohen
Security: LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: LENZ
Shares outstanding: 28,286,479 shares
Disclosed Ownership: 1,357,751 shares
Ownership: 4.8%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 16:03:42 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (6)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Point72 Asset Management, L.P.	1.2%	340,000	340,000	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc.	1.2%	340,000	340,000	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Point72 Biotech Private Investments, LLC	3.6%	1,017,751	1,017,751	/s/ Vincent Tortorella	Vincent Tortorella, Authorized Person
Differentiated Ventures Investments, LLC	3.6%	1,017,751	1,017,751	/s/ Vincent Tortorella	Vincent Tortorella, Authorized Person
72 Investment Holdings, LLC	3.6%	1,017,751	1,017,751	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Steven A. Cohen	4.8%	1,357,751	1,357,751	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person